Therapeutic potential of regulatory RNAs Flashcards

1
Q

What can siRNAs do to a mutated genes mRNA?

A

“knock-down” the mRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which body cells possess the machinery which constitutes a functional siRNA/miRNA pathway?

A

All body cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What takes up siRNAs?

A

RISC complex (RNA Induced Silencing Complex)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does the RISC complex use siRNA for?

A

A scanning target for mRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What happens to mRNA with sequence complementarity to siRNA?

A

It is bound by the siRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What happens to mRNA once bound to siRNA?

A

It is degraded by enzymatic components of the RISC complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What kind of organisms use siRNA/RISC to combat viral infection?

A

Plants and other lower organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do plants and other lower organisms use RISC for?

A

A means of combating viral infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is siRNA manipulated by scientists?

A

an siRNA that has sequence complementarity to any mRNA of interest is designed and this can be used to knock down mRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is an example of a type of gene that siRNA can be used to target?

A

Oncogenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the philadelphia chromosome?

A

A fusion of chromosome 9 and 21

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the issue with the philadelphia chromosome?

A

Where the chromosomes fuse creates a BCR-ABL oncogene which is cancerous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is caused by the BCR-ABL oncogene?

A

Leukaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How can siRNA help therapeutically with leukaemia?

A

siRNA against fusion point between BCR and ABL gene is designed,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why is the siRNA against leukaemia on the philadelphia chromosome targeted specifically against the fusion point of the BCR and ABL gene?

A

So it doesn’t target any normal BCR or ABL genes that aren’t fused

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Where is the BCR gene found?

A

Chromosome 22

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Where is the ABL gene found?

A

Chromosome 9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Why is siRNA a useful way of targeting viral infections?

A

siRNA can be quickly redesigned to keep up with mutations of the virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Why can siRNAs not be given orally?

A

The acid contents in the stomach degrades siRNAs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How must siRNAs be adminitered?

A

Intravenously

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is an issue with administering siRNAs intravenously?

A

There are exonucleases in the blood that will recognise the siRNAs as foreign and start to degrade them, as well as immune cells that do the same thing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Issue with siRNA size?

A

They are rapidly filtered by the kidneys and so cleared

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Issue with siRNAs and plasma membrane?

A

They have an overall -ve charge (RNA phosphate backbone) so they can not cross cell membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How is the immune response to siRNAs combated?

A

You can change the RNA structure that repels the immune system and exonucleases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What edits are done to siRNA to prevent exonucleases and the immune system from attacking?

A

Add a 2’ O-methyl group instead of a hydroxyl group, phosphorothionate linkages

26
Q

In what direction do most exonucleases act?

A

5’ to 3’

27
Q

How does adding a 2’ O-methyl group to siRNA prevent exonuclease degradation?

A

Recognition from the exonuclease is prevented

28
Q

What do phosphorothioate linkages replace?

A

Phosphodiester bonds

29
Q

Difference between phosphodiester bonds and phosphorothioate bond?

A

Oxygen atom is changed to a sulfur

30
Q

What are locked nucleic acids?

A

Altered structures of DNA or RNA, not strictly DNA or RNA–> they are synthetic nucleic acids

31
Q

Features of locked nucleic acids?

A

Oxygen present at the 2’ carbon which is crosslinked to carbon at position 4

32
Q

Why are locked nucleic acids used?

A

Exonucleases and the immune system wont recognise them

33
Q

Benefit of locked nucleic acids other than not being recognised?

A

They bind more potently to their targets than siRNAs do

34
Q

How are siRNAs helped to cross the cell membrane?

A

They are encased in lipid nanoparticles

35
Q

What types of lipids make up lipid nanoparticles?

A

Neutral lipids and cationic lipids

36
Q

How is the -ve charge of siRNAs neutralised?

A

Cationic lipids are +vely charged

37
Q

How is the molecular weight of siRNAs increased?

A

Polyethylene groups

38
Q

Which two things to lipid nanoparticles do that helps siRNAs?

A

Remove the -ve charge and increase their molecular weight

39
Q

When are lipid nanoparticles used?

A

When a systematic delivery is wanted

40
Q

What type of delivery is used when you want to deliver siRNAs to a specific organ or cell type?

A

Targeted delivery

41
Q

What encases siRNAs in targeted delivery?

A

Targeted cationic polymers

42
Q

What make up targeted cationic polymers?

A

polycations, polyethylene groups, targeting ligand

43
Q

What is the targeting ligand specific to in targeted delivery?

A

A receptor on the surface of the cell/organ you are aiming for

44
Q

How is the polymer nanoparticle taken up in targeted delivery?

A

Receptor mediated endocytosis

45
Q

Issues with receptor mediated endocytosis?

A

The molecules are not readily released from the endosome

46
Q

What happens if the contents of an endosome is not readily released?

A

They get transferred to a lysosome where they are degraded

47
Q

What is endosomal escape?

A

The release of something from an endosome

48
Q

What is used to aid endosomal escape?

A

Using proton sponge groups

49
Q

Where are proton sponge groups added?

A

siRNA complex

50
Q

What do proton sponge groups do?

A

Cause protons to be pumped into the endosome, eventually causing it to burst

51
Q

Examples of successful in vivo trials?

A

Haemophilia, ebola

52
Q

What causes hemophilia?

A

mutations in clotting factors, so they are not produced–> persistent bleeding

53
Q

Where are clotting factors produced and what with?

A

In the liver, with anticoagulants

54
Q

Method of targeting hemophilia with siRNAs?

A

Targeting anti clotting factors, restoring the balance between clotting factors and bleeding factors

55
Q

Successful siRNA of hemophilia?

A

Attaching GalNAc groups (ligands) to antithrombin siRNAs

56
Q

What do GalNAc groups do?

A

Bind to proteins found on the surface of liver cells

57
Q

Which ligand does GalNAc attach to?

A

ASGPR receptor

58
Q

Result of GalNAc siRNA?

A

Reduced levels of antithrombin being produced

59
Q

How was siRNA used against ebola?

A

siRNA designed against murkona strain of ebola

60
Q

What kind of delivery was used for the ebola siRNA?

A

LMP (systematic delivery)

61
Q

Which animals were used to test the ebola siRNA and did it work?

A

Monkeys, and yes